Cite
HARVARD Citation
Dal Bello, M. et al. (n.d.). Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors. International journal of cancer. 137 (12), pp. 2947-2958. [Online].